Uipath [PATH] vs Microsoft [MSFT] Detailed Stock Comparison
Uipath
NYSE
Loading...
Microsoft
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Uipath wins in 9 metrics, Microsoft wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Uipath | Microsoft | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -83.65 | 39.67 | Uipath |
| Price-to-Book Ratio | 3.46 | 11.86 | Uipath |
| Debt-to-Equity Ratio | 4.65 | 32.63 | Uipath |
| PEG Ratio | 4.18 | 34.36 | Uipath |
| EV/EBITDA | -50.80 | 25.77 | Uipath |
| Profit Margin (TTM) | -4.65% | 35.79% | Microsoft |
| Operating Margin (TTM) | -3.76% | 45.67% | Microsoft |
| EBITDA Margin (TTM) | N/A | 45.67% | N/A |
| Return on Equity | -3.62% | 33.61% | Microsoft |
| Return on Assets (TTM) | -2.32% | 14.58% | Microsoft |
| Free Cash Flow (TTM) | $305.64M | $74.07B | Microsoft |
| Dividend Yield | N/A | 0.86% | N/A |
| 1-Year Return | -9.99% | 21.70% | Microsoft |
| Price-to-Sales Ratio (TTM) | 4.05 | 14.14 | Uipath |
| Enterprise Value | $4.50B | $3,843.57B | Microsoft |
| EV/Revenue Ratio | 3.10 | 14.24 | Uipath |
| Gross Profit Margin (TTM) | 82.09% | 68.72% | Uipath |
| Revenue per Share (TTM) | $3 | $36 | Microsoft |
| Earnings per Share (Diluted) | $-0.12 | $12.95 | Microsoft |
| Beta (Stock Volatility) | 1.03 | 1.03 | Uipath |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Uipath vs Microsoft Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Uipath | 2.57% | 1.92% | -11.28% | -9.48% | -15.63% | -13.61% |
| Microsoft | 0.59% | -2.49% | 0.39% | 11.51% | 25.55% | 21.18% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Uipath | -9.99% | -34.10% | -85.07% | -85.07% | -85.07% | -85.07% |
| Microsoft | 21.70% | 89.20% | 121.58% | 1,054.63% | 2,019.64% | 1,780.72% |
Performance & Financial Health Analysis: Uipath vs Microsoft
| Metric | PATH | MSFT |
|---|---|---|
| Market Information | ||
| Market Cap | $5.88B | $3.82T |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 10,202,737 | 16,039,860 |
| 90 Day Avg. Volume | 12,737,896 | 18,638,250 |
| Last Close | $11.17 | $507.23 |
| 52 Week Range | $9.38 - $15.93 | $344.79 - $555.45 |
| % from 52W High | -29.88% | -8.68% |
| All-Time High | $90.00 (May 24, 2021) | $555.45 (Jul 31, 2025) |
| % from All-Time High | -87.59% | -8.68% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.13% |
| Quarterly Earnings Growth | 0.06% | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | -0.05% | 0.36% |
| Operating Margin (TTM) | -0.04% | 0.46% |
| Return on Equity (TTM) | -0.04% | 0.34% |
| Debt to Equity (MRQ) | 4.65 | 32.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.18 | $43.30 |
| Cash per Share (MRQ) | $2.91 | $10.71 |
| Operating Cash Flow (TTM) | $339.53M | $130.71B |
| Levered Free Cash Flow (TTM) | $471.82M | $54.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.86% |
| Last 12-Month Dividend | N/A | $4.07 |
Valuation & Enterprise Metrics Analysis: Uipath vs Microsoft
| Metric | PATH | MSFT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -83.65 | 39.67 |
| Forward P/E | 24.98 | 34.36 |
| PEG Ratio | 4.18 | 34.36 |
| Price to Sales (TTM) | 4.05 | 14.14 |
| Price to Book (MRQ) | 3.46 | 11.86 |
| Market Capitalization | ||
| Market Capitalization | $5.88B | $3.82T |
| Enterprise Value | $4.50B | $3.84T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.10 | 14.24 |
| Enterprise to EBITDA | -50.80 | 25.77 |
| Risk & Other Metrics | ||
| Beta | 1.03 | 1.03 |
| Book Value per Share (MRQ) | $3.18 | $43.30 |
Financial Statements Comparison: Uipath vs Microsoft
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PATH | MSFT |
|---|---|---|
| Revenue/Sales | $356.62M | $70.07B |
| Cost of Goods Sold | $63.86M | $21.92B |
| Gross Profit | $292.77M | $48.15B |
| Research & Development | $94.84M | $8.20B |
| Operating Income (EBIT) | $-16.41M | $32.00B |
| EBITDA | $-13.16M | $40.32B |
| Pre-Tax Income | $-19.73M | $31.38B |
| Income Tax | $2.83M | $5.55B |
| Net Income (Profit) | $-22.56M | $25.82B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PATH | MSFT |
|---|---|---|
| Cash & Equivalents | $700.64M | $28.83B |
| Total Current Assets | $2.11B | $156.64B |
| Total Current Liabilities | $715.87M | $114.21B |
| Long-Term Debt | $73.43M | $57.57B |
| Total Shareholders Equity | $1.70B | $321.89B |
| Retained Earnings | $-2.01B | $219.76B |
| Property, Plant & Equipment | $66.98M | $295.49B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PATH | MSFT |
|---|---|---|
| Operating Cash Flow | $195.89M | $36.04B |
| Capital Expenditures | $-12.83M | $-16.75B |
| Free Cash Flow | $106.17M | $20.30B |
| Debt Repayment | N/A | $-2.25B |
| Common Stock Repurchase | $-227.53M | $-4.78B |
Short Interest & Institutional Ownership Analysis
| Metric | PATH | MSFT |
|---|---|---|
| Shares Short | 54.95M | 53.79M |
| Short Ratio | 4.37 | 2.76 |
| Short % of Float | 0.15% | 0.01% |
| Average Daily Volume (10 Day) | 10,202,737 | 16,039,860 |
| Average Daily Volume (90 Day) | 12,737,896 | 18,638,250 |
| Shares Outstanding | 553.51M | 7.43B |
| Float Shares | 422.75M | 7.42B |
| % Held by Insiders | 0.08% | 0.00% |
| % Held by Institutions | 0.82% | 0.75% |
Dividend Analysis & Yield Comparison: Uipath vs Microsoft
| Metric | PATH | MSFT |
|---|---|---|
| Last 12-Month Dividend | N/A | $4.07 |
| Last 12-Month Dividend Yield | N/A | 0.86% |
| 3-Year Avg Annual Dividend | N/A | $3.22 |
| 3-Year Avg Dividend Yield | N/A | 0.21% |
| 3-Year Total Dividends | N/A | $9.66 |
| Ex-Dividend Date | N/A | Aug 21, 2025 |